Heron Therapeutics, Inc. · NASDAQ:HRTX
Heron Therapeutics, Inc. shareholders
As of Jun 30, 2026, 156 institutions reported holding Heron Therapeutics, Inc., 70.4% of its shares. Largest: Rubric Capital Management LP, Clearline Capital LP and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Heron Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Rubric Capital Management LP | 30M | 15.8% | no change | Aug 14, 2026 |
| Clearline Capital LP | 11.4M | 6.0% | −851K | Aug 14, 2026 |
| Vanguard | 10.8M | 5.7% | +470K | Aug 13, 2026 |
| BlackRock | 10.6M | 5.6% | +444K | Aug 7, 2026 |
| Velan Capital Investment Management LP | 8.75M | 4.6% | no change | Aug 14, 2026 |
| Tejara Capital Ltd | 6.51M | 3.4% | +174K | Aug 11, 2026 |
| Tang Capital Management LLC | 6.25M | 3.3% | no change | Aug 14, 2026 |
| Geode Capital | 4.27M | 2.2% | +261K | Aug 12, 2026 |
| Millennium | 4.07M | 2.1% | −3.56M | Aug 14, 2026 |
| JW Asset Management, LLC | 3.75M | 2.0% | no change | Aug 7, 2026 |